Meet FoBiG employee Karin Heine at the ESTIV Congress 2018 from 15.-18. October in Berlin. She presents the in vitro test strategy and results from a project, which assessed the sensitizing potency of epoxy resin ingredients (P 142). The project was funded by the German Social Accident Insurance (DGUV) and the final report is available (DGUV FP-0384).
For further Information, please contact Karin Heine.